After a strong 2024 rally that saw Solana (SOL) surge significantly on the back of growing DeFi activity and institutional interest, many investors are now searchingAfter a strong 2024 rally that saw Solana (SOL) surge significantly on the back of growing DeFi activity and institutional interest, many investors are now searching

Missed Solana (SOL) 2024 Rally? Investors Are Watching This Crypto Under $1

2026/03/18 20:26
5 min read
For feedback or concerns regarding this content, please contact us at [email protected]

After a strong 2024 rally that saw Solana (SOL) surge significantly on the back of growing DeFi activity and institutional interest, many investors are now searching for the next high-growth opportunity in the crypto market. As SOL consolidates following its breakout performance, gaining as much as 80%+ during the year, attention is shifting toward emerging low-cost tokens

Solana (SOL)

As of March 17, 2026, Solana (SOL) is showing signs of a tentative recovery. The token is currently trading near $93.69, having climbed roughly 7% over the last 24 hours. This move follows a period of consolidation where the asset tested lower support levels near the $77 to $82 range. With a market capitalization holding steady at approximately $53.5 billion, Solana remains a dominant force in the layer-1 sector. Its network activity remains high, processing millions of daily transactions, and it recently celebrated its sixth anniversary since the genesis block.

Missed Solana (SOL) 2024 Rally? Investors Are Watching This Crypto Under $1

Despite this recent strength, Solana faces a challenging technical ceiling. The most immediate resistance zone is located between $95 and $98. Analysts observe that a clean close above the $100 mark is required to signal a long-term trend reversal. Until that level is reclaimed with significant volume, the asset remains vulnerable to pullbacks. Much of the positive news, including the Alpenglow upgrade and steady institutional ETF inflows, appears to be already factored into the current valuation. Because it is a multi-billion dollar project, doubling its value would require an immense inflow of new capital, leading many to search for opportunities with higher percentage elasticity.

Mutuum Finance (MUTM)

As interest in larger assets begins to plateau, Mutuum Finance (MUTM) is emerging as a primary target for rotating capital. This protocol is an Ethereum-based platform built for an automated system of non-custodial borrowing and lending. It aims to remove the friction found in traditional models by offering two distinct ways for users to interact with capital. Its Peer to Contract (P2C) market uses automated pools where lenders provide liquidity, while its Peer to Peer (P2P) marketplace allows for direct agreements with custom terms between parties.

The financial progress of this protocol reflects a strong interest in its technical goals. Mutuum Finance has successfully raised over $21.42 million in capital. This funding is provided by a global base of more than 19,200 individual holders. The project recently reached a major milestone with the activation of its V1 protocol on the testnet. This working version has already handled over $230 million in simulated volume, proving that the core engine is ready for the next stage of growth. This transition from a conceptual plan to a ready-to-use tool is a primary catalyst for the current wave of participation.

Rotation Logic and Price Projections

The logic behind the current market rotation is a contrast between late-cycle and early-cycle opportunities. Solana is currently an expensive, late-cycle asset. To see a significant move, it requires billions in new liquidity. For many participants, the potential for a 2x or 3x return on a $50 billion asset is a long-term prospect. In contrast, Mutuum Finance is an inexpensive, early-cycle protocol. Because its valuation is still a fraction of the major networks, it has the elasticity to provide much higher percentage gains.

The native MUTM token is currently in Phase 7 of its distribution at a price of $0.04. Since the start of the first phase at $0.01 in early 2025, the token has already seen a 300% surge in value. With an official launch price confirmed at $0.06, current participants are looking at a 50% jump in value by the time the token reaches the wider market. Analysts who track the sector believe the token is on a path to test the $0.30 to $0.45 range by late 2026. This projection is backed by the successful V1 test results and the project’s ability to capture a share of the borrowing market as it moves toward its final release.

Infrastructure Readiness and Security Standards

The momentum behind Mutuum Finance is driven by its technical delivery. The V1 protocol features active liquidity pools for USDT, ETH, LINK, and WBTC. It uses mtTokens as interest-bearing receipts for lenders and Debt Tokens to track obligations for borrowers. This modern approach to capital management includes “one-click” functionality for managing positions and automated notifications to help users stay informed about their collateral levels.

Security is also a top priority for the project. Mutuum Finance has completed a full manual audit by Halborn Security, a firm famous for reviewing the most complex systems in the industry. Additionally, the project holds a high safety score of 90/100 from CertiK, which includes a detailed scan of the smart contract logic. To keep the community active, the platform features a 24-hour leaderboard that rewards the top daily contributor with a $500 bonus in tokens. By combining audited safety with a finished lending marketplace, Mutuum Finance is positioning itself as a primary hub for the 2026 cycle.

For more information about Mutuum Finance (MUTM) visit the links below:

Website: https://www.mutuum.com

Linktree: https://linktr.ee/mutuumfinance

Comments
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Share
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Share
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26